Medical Diagnostics

BioScale, Inc.

Brief Description

BioScale developed diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes, and cardiovascular disease. The company's algorithms utilized combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. BioScale's rigorous approach to test development included collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts.

Bioscale...

BioAmp Diagnostics

Brief Description

BioAmp develops novel, instrument-free screening and diagnostic tools to identify antibiotic-resistant bacteria in patient samples.

Timeline 2017. Company founded, and participated in the Citris Foundry accelerator program Inventors

Tara DeBoer, Niren Murthy, Jessica Marie Palomino, Lee Woodland Riley

Rewrite Therapeutics

Brief Description

Rewrite Therapeutics accelerates drug development using a proprietary CRISPR-based evolution platform. For more information, contact Shakked Halperin.

Formerly known as Evolve Biotech, and Rewrite Biotech.

The company was acquired by Intellia Therapeutics in 2022.

Timeline 2018. Company founded 2022. Acquired by Intellia Therapeutics Inventor

Shakked Halperin

Synvivia, Inc.

Brief Description Synvivia is an early-stage Synthetic Biology startup located in QB3-EBIC in Berkeley, CA. Synvivia's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine.

Synvivia has exclusive license to IP in all fields of use. Backed by Y Combinator, the National Institutes of Health, and industrial partnership, Synvivia is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory...

Tenaya Therapeutics

Brief Description

Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. Founded in 2016 by leading cardiology researchers at the Gladstone Institutes and UT Southwestern, Tenaya is backed by a top-tier syndicate of investors.

Inventors Bruce Conklin, Kevin...

GenEdit, Inc.

BRIEF DESCRIPTION

GenEdit was founded by UC Berkeley scientists who developed targeted delivery technologies for CRISPR therapeutics. The GenEdit founders share the vision that recent scientific advancements in engineering CRISPR components and delivery vehicles offer a groundbreaking opportunity to develop safe and effective medicines for genetic diseases.

Our proprietary Polymer nanoparticle can deliver CRISPR protein and gRNA. Despite CRISPR in a protein form has many advantages, delivery has been a challenge limiting its application. To deliver CRISPR protein, encapsulation of...

Lucira Health

Brief Description Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Formerly known as Diassess, Inc.

Lucira Health was acquired by Pfizer (NYS: PFE) in 2023.

Timeline 2013....

Correlia Biosystems, Inc.

Brief Description Correlia Biosystems develops streamlined assay platforms to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications. Our research instruments provide multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation. We are dedicated to reducing the cost and time to market for candidate drug compounds, and facilitating the access of researchers to large panel protein studies. Inventors

Akwasi Apori, Muhammet Araz, Amy Herr

Xip Diagnostics

Brief Description Xip Diagnostics develops analytical solutions that advance human and animal health at the point of need through in-house product development and industry-leading collaborations.

The company's disposable blood analyzers wirelessly upload lab-quality clinical measurements in minutes, providing blood testing with no hassles, no delays, and no instrument. These devices will be deployed in Emergency Departments (EDs), clinics, and eventually the home.

Formerly known as Integrated Diagnostics, and then Silicon BioDevices LLC.

Timeline 2009. Company...

CellScope Inc.

Brief Description

CellScope’s mission is to make healthcare more accessible and convenient. We are building smart mobile tools to empower families with easy access to health answers and care when they need it most.

CellScope was acquired. The details are not yet public.

Timeline 2010. Company founded Inventor David Breslauer, Jesse Dill, Erik Douglas, Daniel Fletcher, Wendy Hansen, Wilbur Lam, Robi Maamari, Amy Sheng, Neil Switz